Retinal Physician – Gene Therapy Implications for Retina Specialists
[ad_1] Just published, “Gene Therapy Implications for Retina Specialists: Evolving endpoints, novel orphan disease treatment paradigms, and the dawn of precision medicine.” The approval and launch of Spark’s LUXTURNA (voretigene neparvovec-ryzl), the first FDA-approved gene therapy for a genetic disease, introduces novel paradigms to clinical …